日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Glutamate dehydrogenase (GLUD1) expression in breast cancer

乳腺癌中的谷氨酸脱氢酶(GLUD1)表达

Madeleine L Craze, Rokaya El-Ansari, Mohammed A Aleskandarany, Kiu Wai Cheng, Lutfi Alfarsi, Brendah Masisi, Maria Diez-Rodriguez, Christopher C Nolan, Ian O Ellis, Emad A Rakha, Andrew R Green

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes

介质复合物 (MED) 7:一种与浸润性乳腺癌(尤其是 ER+ 腔内亚型)良好预后相关的生物标志物

Chitra Joseph, Olivia Macnamara, Madeleine Craze, Roslin Russell, Elena Provenzano, Christopher C Nolan, Maria Diez-Rodriguez, Sultan N Sonbul, Mohammed A Aleskandarany, Andrew R Green, Emad A Rakha, Ian O Ellis, Abhik Mukherjee

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes

多功能溶质载体 3A2(SLC3A2)在高度增殖的乳腺癌亚型中预后不良

Rokaya El Ansari, Madeleine L Craze, Maria Diez-Rodriguez, Christopher C Nolan, Ian O Ellis, Emad A Rakha, Andrew R Green

MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer

MYC 调节谷氨酰胺-脯氨酸调节轴是管腔 B 型乳腺癌的关键

Madeleine L Craze, Hayley Cheung, Natasha Jewa, Nuno D M Coimbra, Daniele Soria, Rokaya El-Ansari, Mohammed A Aleskandarany, Kiu Wai Cheng, Maria Diez-Rodriguez, Christopher C Nolan, Ian O Ellis, Emad A Rakha, Andrew R Green

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

氨基酸转运蛋白 SLC7A5 在高度增殖的乳腺癌亚型中预后不良,是管腔 B 肿瘤的关键治疗靶点

Rokaya El Ansari, Madeleine L Craze, Islam Miligy, Maria Diez-Rodriguez, Christopher C Nolan, Ian O Ellis, Emad A Rakha, Andrew R Green

Phenotypic characterisation of breast cancer: the role of CDC42

乳腺癌的表型特征:CDC42 的作用

Eleni Chrysanthou, Kylie L Gorringe, Chitra Joseph, Madeleine Craze, Christopher C Nolan, Maria Diez-Rodriguez, Andrew R Green, Emad A Rakha, Ian O Ellis, Abhik Mukherjee